Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
| Id | http://purl.bioontology.org/ontology/NDFRT/N0000007406
http://purl.bioontology.org/ontology/NDFRT/N0000007406
|
|---|---|
| Preferred Name | Auranofin [Chemical/Ingredient] |
| Synonyms |
Auranofin
Gold, (1-thio-beta-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
Auranofin
Gold, (1-thio-beta-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-
|
|---|---|
| prefLabel | Auranofin [Chemical/Ingredient]
|
| MESH DEFINITION | An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.
|
| MESH DUI | D001310
|
| MESH UI | M0001971
|
| MeSH name | Auranofin
|
| type | |
| tui |
T109
T121
|
| notation | N0000007406
|
| Semantic type UMLS property | |
| NUI | N0000007406
|
| Ingredient of | |
| cui | C0004320
|
| NDFRT kind | INGREDIENT_KIND
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |